Two protocols for quickly and safely evaluating patients presenting to emergency departments with chest pain are being adopted by Australian hospitals.
Chest pain is one of the most common reasons patients present to emergency departments (ED), with about 500,000 cases of chest pain presentations to emergency departments in Australia each year (about six million annually in the United States of America ).
However, the majority of patients are not at risk of having a heart attack, according to Professor William Parsonage, a Cardiologist at the Royal Brisbane and Women's Hospital (RBWH) and Clinical Director of the Australian Centre for Health Services Innovation at the Queensland University of Technology.
"Emergency departments are buckling under pressure from increasing numbers of patient presentations so a really important driver for our research was finding new ways that are safe and efficient for assessing patients with chest pain. Our aim was to improve the efficiency of excluding those patients at high risk of having a heart attack, or acute coronary syndrome (ACS), while reducing the burden of assessment for low and intermediate risk patients."
Professor Parsonage, along with Professor Louise Cullen, a Pre-eminent Staff Specialist in Emergency Medicine at the RBWH, jointly led a team who developed two new protocols for assessing chest pain, which were the subject for two landmark publications published recently in the Medical Journal of Australia.
The first paper describes the results of the introduction of the two-hour Accelerated Diagnostic Protocol (ADP) to Assess Patients with chest pain symptoms using contemporary Troponins as the only biomarker to 16 Queensland Emergency Departments.
An economic evaluation estimated $13.5 million in savings per year for Queensland hospitals in released financial capacity as a direct result of using the ADP.
The ADP was introduced during October 2013 to November 2015 with funding from Queensland Health. Outcomes were recorded for 30,769 patients presenting before, and 23,699 presenting after, the ADP was introduced. Following its implementation, 21.3% of patients were identified correctly by the ADP as being at low risk for an ACS; the mean emergency department length of stay for all patients presenting with chest pain fell from 292 to 256 minutes. The mean hospital length of stay fell from 57.7 to 47.3 hours, and the hospital admission rate fell from 68.3% to 54.9%.
The second paper describes the IMProved Assessment of Chest pain Trial (IMPACT), a novel strategy to safely improve the care of 70 per cent of ED patients with suspected acute coronary syndromes, funded by the Emergency Medicine Foundation of Australia (EMF).
IMPACT is changing the care doctors give to chest pain patients by improving the efficiency and maintaining the safety of assessing patients with chest pain, said Professor Cullen.
"The protocol allows us to identify low risk patients, who account for nearly 1 in 5 chest pain patients in the emergency department, and safely discharge them within five hours, avoiding unnecessary tests," she said.
"Significantly, IMPACT additionally helps us correctly identify nearly 60 per cent of patients who are at an intermediate risk of having a heart attack. We have shortened the duration of testing for this group so that patients with heart disease can be identified early and admitted and those without can be safely sent home in seven and a half hours compared with 24 hours using traditional care."
In a health economic analysis it was estimated that if all Queensland hospitals adopted IMPACT, it would result in released capacity worth $12.4 million annually.
IMPACT was investigated at the RBWH during February 2011 to March 2014, with 1366 patients presenting to the ED with symptoms of suspected ACS stratified into groups at low, intermediate or high risk of an ACS. Low and intermediate risk patients underwent troponin testing at presentation and two hours later. Intermediate risk patients underwent objective testing after the second troponin test and low risk patients were discharged without further objective testing. Care for high risk patients was unchanged.
The IMPACT protocol stratified 244 (17.9%) patients to low risk and 789 (57.7%) to intermediate risk. The overall 30-day ACS rate was 6.6%, but there were no ACS events in the low risk group, and 14 (1.8%) in the intermediate risk group. The median hospital length of stay was 5.1 hours for low risk and 7.7 hours for intermediate risk patients.
The research team's latest strategy is being rolled out to hospitals in Queensland with funding from Queensland Health's Clinical Excellence Division. The protocol is live at the RBWH, Cairns, Nambour, Ipswich and the Sunshine Coast University Hospital.
EMF Chair, Dr Anthony Bell said investing in emergency medicine research allowed clinicians to deliver valuable solutions to patient care.
"Professor Cullen and her research team knew from first-hand experience that only one in five people with chest pain in the emergency department was at risk of having a heart attack," said Dr Bell.
"With dedicated research funding, they were able to develop an evidence-based solution that reduces the amount of testing needed for the majority of patients, while still maintaining clinical safety. It's a win for patients and the emergency department. The majority of patients with chest pains get to go home sooner knowing that they aren't having a heart attack, and we can spend more time treating people who are acutely ill."
EMF awarded more than $1 million in research grants to Professor Louise Cullen to develop strategies to improve chest pain assessment. The EMF Queensland Research Program is funded by Queensland Health.
Explore further: Rule could take one-third of chest pain patients off emergency department heart monitors
Louise Cullen et al, Improved Assessment of Chest pain Trial (IMPACT): assessing patients with possible acute coronary syndromes, The Medical Journal of Australia (2017). DOI: 10.5694/mja16.01351